Citations

Citations to this article as recorded by  

• Current approaches to managing inflammatory bowel disease in the elderly – A literature review
  Maciej Zamorski, Agata Stebel, Alicja Gładysz
  Annales Academiae Medicae Silesiensis.2026; 80: 155.     CrossRef
• Clinical characteristics and treatment patterns of older and younger patients with inflammatory bowel disease
  Fatih Kivrakoglu, Vedat Kilic, Mustafa Ergin, Harun Kucuk, Cagdas Erdogan, Ilhami Yuksel
  World Journal of Gastroenterology.2026;[Epub]     CrossRef
• Inflammatory bowel disease in south Asia: a scoping review
  Shabari Shenoy, Anuraag Jena, Carrie Levinson, Vishal Sharma, Parakkal Deepak, Tina Aswani-Omprakash, Shaji Sebastian, Jean-Frederic Colombel, Manasi Agrawal
  The Lancet Gastroenterology & Hepatology.2025; 10(3): 259.     CrossRef
• Metabolic Disorders and Inflammatory Bowel Diseases
  Hye Kyung Hyun, Jae Hee Cheon
  Gut and Liver.2025; 19(3): 307.     CrossRef
• Elderly-onset inflammatory bowel disease in Asia: clinical characteristics and therapeutic strategies
  Jiyoung Yoon, Daein Kim, You Sun Kim
  Intestinal Research.2025; 23(4): 430.     CrossRef
• Inflammatory Bowel Disease in the Elderly
  Rachid El Jim, Chaimae Maroute, Asmae Lamine, Maria Lahlali, Hakima Abid, Nada Lahmidani, Amine El Mekkaoui, Mounia El Yousfi, Dafr-Allah Benajah, Sidi Adil Ibrahimi, Mohammed El Abkari
  Open Journal of Gastroenterology.2025; 15(07): 376.     CrossRef
• Impact of age at diagnosis on long‐term prognosis in patients with intestinal Behçet's disease
  Ji Young Chang, Soo Jung Park, Jae Jun Park, Tae Il Kim, Jae Hee Cheon, Jihye Park
  Journal of Gastroenterology and Hepatology.2024; 39(3): 519.     CrossRef
• Neither hepatic steatosis nor fibrosis is associated with clinical outcomes in patients with intestinal Behçet’s disease
  Hye Kyung Hyun, Jihye Park, Soo Jung Park, Jae Jun Park, Tae Il Kim, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Seung Up Kim, Jae Hee Cheon
  European Journal of Gastroenterology & Hepatology.2024; 36(4): 445.     CrossRef
• Inflammatory bowel disease: a narrative review of disease evolution in South Asia and India over the last decade
  Sahana Shankar, Snehali Majumder, Suparna Mukherjee, Anirban Bhaduri, Rangarajan Kasturi, Subrata Ghosh, Marietta Iacucci, Uday N. Shivaji
  Therapeutic Advances in Gastroenterology.2024;[Epub]     CrossRef
• A prospective study of inflammatory bowel disease phenotypes in extremes of age and comparison with adults
  Nikhil Bhangale, Devendra Desai, Philip Abraham, Tarun Gupta, Pavan Dhoble, Anand Joshi
  Indian Journal of Gastroenterology.2023; 42(3): 404.     CrossRef
• Global Epidemiology and Burden of Elderly-Onset Inflammatory Bowel Disease: A Decade in Review
  Pojsakorn Danpanichkul, Kanokphong Suparan, Suchapa Arayakarnkul, Aunchalee Jaroenlapnopparat, Natchaya Polpichai, Panisara Fangsaard, Siwanart Kongarin, Karan Srisurapanont, Banthoon Sukphutanan, Wasuwit Wanchaitanawong, Yatawee Kanjanakot, Jakrapun Pupa
  Journal of Clinical Medicine.2023; 12(15): 5142.     CrossRef

Citations

Citations to this article as recorded by  

• Therapeutic Drug Monitoring and Pharmacogenomics of Thiopurines in Inflammatory Bowel Disease: International Guidelines Revisited
  Ahmed B. Bayoumy, Luc J. J. Derijks, Nanne K. H. de Boer
  Therapeutic Drug Monitoring.2026; 48(3): 400.     CrossRef
• Revisiting thiopurines and therapeutic drug monitoring in IBD: Insights and implications in the Indian context
  Arshdeep Singh, Ajit Sood
  Indian Journal of Gastroenterology.2026; 45(3): 360.     CrossRef
• Unraveling Novel Genetic Determinants of Thiopurine Response Via TWAS
  Carlotta Bidoli, Wenjian Yang, Seth E. Karol, Marianna Lucafò, Gabriele Stocco, Jun J. Yang
  Clinical Pharmacology & Therapeutics.2026; 119(1): 84.     CrossRef
• Targeted therapeutics for IBD unraveling the potential of stimulus-responsive nanoparticles
  Andreia S. Barros, Rute Nunes, Bruno Sarmento
  Journal of Controlled Release.2026; 389: 114466.     CrossRef
• The right drug at the right time: key to IBD success
  Davide Giuseppe Ribaldone, Giulia Valdiserra, Clelia Di Salvo, Ilaria Puxeddu, Lorenzo Bertani, Luca Antonioli
  Trends in Molecular Medicine.2026; 32(7): 658.     CrossRef
• Diagnostic challenges and treatment approaches for Clostridioides difficile infection in IBD patients
  Asghar Ali, Khalid I. AlHussaini
  Frontiers in Microbiology.2026;[Epub]     CrossRef
• Risk of Infection Before and After Thiopurine Therapy in Inflammatory Bowel Disease
  Johanna Holmgren, Alice Akhlaghi, Isabel Drake, Olof Grip
  Journal of Clinical Gastroenterology.2026;[Epub]     CrossRef
• Beyond the binary: understanding inflammatory bowel disease in the context of HIV-induced immunodeficiency
  Harsh Srivastava, Tanisha Sehgal, Vishal Sharma, Himanshu Narang, Jeffrey Berinstein, Ajit Sood, Shrinivas Bishu, Manjeet Kumar Goyal
  Expert Review of Clinical Immunology.2026; 22(3): 307.     CrossRef
• Optimizing mercaptopurine therapy in indian pediatric ALL: The role of TPMT and NUDT15 genetic polymorphisms
  Jayalakshmi Venugopal, Shalini Sivadasan, Rajasekaran Aiyalu
  Cancer Treatment and Research Communications.2026; 47: 101173.     CrossRef
• The decline of 6‐thioguanine nucleotides is not linked to impaired efficacy or safety of thiopurines in pregnant women with inflammatory bowel disease
  Dianne G. Bouwknegt, Paola Mian, Femke Groen, Denise van den Berg‐Zuiddam, Andrea E. van der Meulen, Femke Crouwel, Nanne K. de Boer, Debbie S. Deben, Dennis R. Wong, Luc J. J. Derijks, Gerard Dijkstra, Arno R. Bourgonje, C. Janneke van der Woude, Marijn
  British Journal of Clinical Pharmacology.2026; 92(7): 2364.     CrossRef
• Efficacy and Safety of Etrasimod in Moderate-To-Severe Ulcerative Colitis: A GRADE-Based Systematic Review and Meta-Analysis of Randomized Controlled Trials
  Anurag Jha, Nirmal Paudel, Khawaja Arham Jawaid, Muhammad Haad Munir Chaudhry, Zain Ali, Farhan Javaid, Shazia Sharif, Ayesha Asghar, Muhammad Saad, Muhammad Nabeel Saddique
  Annals of Pharmacotherapy.2026;[Epub]     CrossRef
• Adverse Events Related to Azathioprine Use in Patients With Inflammatory Bowel Disease: A Real‐World Cohort Study
  Mukesh Kumar Ranjan, Pradeep Neupane, Bigyan Maharjan, Manoj Lamsal, Bikash Poudel, Tatsuya Toyokawa
  Gastroenterology Research and Practice.2026;[Epub]     CrossRef
• Colorectal cancer in ulcerative colitis: unraveling mechanisms and advancing surveillance and chemoprevention
  Haiyan Lu, Xiangdang Hu, Yan Chen, Jie He
  Frontiers in Oncology.2026;[Epub]     CrossRef
• Development and Validation of an Ultra-high Performance Liquid Chromatography Method for Simultaneous Quantification of Phosphorylated Thiopurine Metabolites in Patients with Inflammatory Bowel Disease
  Khushboo G. Upadhyay, Mihika B. Dave, Devendra C. Desai, Prasad R. Naik, Sarita D. Pol, Rohan V. Lokhande, Tester F. Ashavaid, Alpa J. Dherai
  Indian Journal of Clinical Biochemistry.2026;[Epub]     CrossRef
• Pharmacogenetic Risk Factors for Thiopurine-Induced Leukopenia in Patients with Inflammatory Bowel Disease
  Eun Kyung Boo, Jongwook Yu, Sohyung Oh, Jae Hee Cheon, Ju Han Kim
  Yonsei Medical Journal.2026; 67(8): 603.     CrossRef
• Disability among Palestinian patients with inflammatory bowel disease: evaluation using the IBD Disk and identification of associated factors
  Ahmed Quraish, Ro’ya Khanfar, Karmil Kharouf, Sami Salous, Dala Quraish, Qusay Abdoh
  Crohn’s & Colitis 360.2026;[Epub]     CrossRef
• The JAK attack: transforming the management of ulcerative colitis in India
  Arshdeep Singh, Arshia Bhardwaj, Vandana Midha, Ajit Sood
  Intestinal Research.2026; 24(3): 392.     CrossRef
• Chronotherapy in Inflammatory Bowel Disease: Biological Rationale, Human Evidence, and a Clinical Implementation Framework
  Khaled H. Husain, Hira Khan, Bianca Thakkar, Musa Bungish, Haleh Vaziri
  Digestive Diseases and Sciences.2026;[Epub]     CrossRef
• Management of pediatric Crohn’s disease: an ECCO-ESPGHAN guideline update
  Dror S Shouval, Iva Hojsak, Erasmo Miele, Christiane Sokollik, Dan Turner, Kaija-Leena Kolho, Rotem Sigall-Boneh, Patrick F van Rheenen, Eytan Wine, Richard K Russell, Seamus Hussey, Neil Chanchlani, Amit Assa, Javier Martin de Carpi, Luca Scarallo, Anne
  Journal of Crohn’s and Colitis.2026;[Epub]     CrossRef
• Low risk of malignancies with thiopurines in an Indian cohort of patients with Inflammatory bowel disease
  Arshdeep Singh, Vandana Midha, Ajit Sood
  Indian Journal of Gastroenterology.2025; 44(3): 390.     CrossRef
• Pharmacogenomic Assessment of Genes Implicated in Thiopurine Metabolism and Toxicity in a UK Cohort of Pediatric Patients With Inflammatory Bowel Disease
  Tracy Coelho, Guo Cheng, Sophie Lewis, James J Ashton, Farah Barakat, Kouros C T Driscoll, Adebola E Sholeye-Bolaji, Akshay Batra, Nadeem A Afzal, Robert M Beattie, Sarah Ennis
  Inflammatory Bowel Diseases.2025; 31(2): 362.     CrossRef
• Saudi consensus guidance for the diagnosis and management of inflammatory bowel disease in children and adolescents
  Omar I. Saadah, Turki AlAmeel, Ahmed Al Sarkhy, Mohammed Hasosah, Abdulrahman Al-Hussaini, Majid A. Almadi, Badr Al-Bawardy, Talal A. Altuwaijri, Mohammed AlEdreesi, Shakir A. Bakkari, Othman R. Alharbi, Nahla A. Azzam, Abdulelah Almutairdi, Khalidah A. A
  Saudi Journal of Gastroenterology.2025; 31(3): 107.     CrossRef
• Immunogenicity of Therapeutic Antibodies Used for Inflammatory Bowel Disease: Treatment and Clinical Considerations
  Ole Haagen Nielsen, Alexander Hammerhøj, Mark Andrew Ainsworth, John Gubatan, Geert D’Haens
  Drugs.2025; 85(1): 67.     CrossRef
• Comparison of Effects on 6-Thioguanine Nucleotides According to Mesalazine Formulation in Pediatric Patients with Ulcerative Colitis
  Hansol Kim, Yoon Zi Kim, Seon Young Kim, Yon Ho Choe, Mi Jin Kim
  Clinical Therapeutics.2025; 47(3): 196.     CrossRef
• Thiopurine S-methyltransferase – An important intersection of drug-drug interactions in thiopurine treatment
  Dunja Urbančič, Marko Jukič, Alenka Šmid, Stanislav Gobec, Janez Jazbec, Irena Mlinarič-Raščan
  Biomedicine & Pharmacotherapy.2025; 184: 117893.     CrossRef
• Effectiveness and safety of thiopurines in inflammatory bowel disease patients with NUDT15 polymorphism: a real-world retrospective study
  Abhirup Chatterjee, Prateek Bhatia, Saroj K Sinha, Anupam K Singh, Harshal S Mandavdhare, Jimil Shah, Vaneet Jearth, Arpit Sasani, Aravind Sekar, Minu Singh, Usha Dutta, Vishal Sharma
  Expert Review of Clinical Pharmacology.2025; 18(3): 175.     CrossRef
• Cutting Edge: A Comprehensive Guide to Colorectal Cancer Surgery in Inflammatory Bowel Diseases
  Ionut Iordache, Lucian-Flavius Herlo, Razvan Popescu, Daniel Costea, Luana Alexandrescu, Adrian Suceveanu, Sorin Deacu, Gabriela Baltatescu, Alina Nicoara, Nicoleta Leopa, Andreea Nelson Twakor, Andrei Iordache, Liliana Steriu
  Journal of Mind and Medical Sciences.2025; 12(1): 6.     CrossRef
• Perspectives in clinical research on Azathioprine for steroid-dependent ulcerative colitis
  Yuan-Ting Qu, Jia-Yuan Ding, Wei Pan, Fang-Rui Liu, Ai-Lian Dong
  Frontiers in Medicine.2025;[Epub]     CrossRef
• Therapeutic Drug Monitoring of Thiopurines in Patients With Inflammatory Bowel Disease: Observations From Daily Practice
  Mila Lovrić, Kristina Dukić, Silvija Čuković-Čavka, Lana Ganoci, Nada Božina, Vladimir Trkulja
  Therapeutic Drug Monitoring.2025; 47(5): 676.     CrossRef
• Risk of malignancies and chemopreventive effect of statin, metformin, and aspirin in Korean patients with ulcerative colitis: a nationwide population-based study
  Eun Hye Oh, Ye-Jee Kim, Minju Kim, Seung Ha Park, Tae Oh Kim, Sang Hyoung Park
  Intestinal Research.2025; 23(2): 129.     CrossRef
• The fate of thiopurine metabolites after switching to low‐dose thiopurine with allopurinol or thioguanine in IBD patients: A retrospective analysis
  Ahmed B. Bayoumy, Hedwig M. A. D'Agnolo, Nanne K. H. de Boer, Chris J. J. Mulder, Luc J. J. Derijks
  British Journal of Clinical Pharmacology.2025; 91(10): 2865.     CrossRef
• Comparing Outcomes With Subcutaneous Infliximab (CT-P13 SC) by Baseline Immunosuppressant Use: A Post Hoc Analysis of the LIBERTY-CD and LIBERTY-UC Studies
  Stefan Schreiber, Jean-Frederic Colombel, Stephen B Hanauer, William J Sandborn, Silvio Danese, Sang Joon Lee, Sung Hyun Kim, Yun Ju Bae, Sun Hee Lee, Seul Gi Lee, Joon Ho Lee, Jong Min Kim, Ga Hee Park, Jimin Lee, Ju Hyun Lee, Chae Young Kim, Bruce E San
  Inflammatory Bowel Diseases.2025; 31(10): 2714.     CrossRef
• NDP52 and its emerging role in pathogenesis
  Krenare Bruqi, Flavie Strappazzon
  Cell Death & Disease.2025;[Epub]     CrossRef
• Gut microbial healing in IBD: visionary approach or evidence-based reality?
  Linda Nanni, Marco Murgiano, Chieh-En Hsu, Sheida Khalili, Giovanni Cammarota, Alfredo Papa, Antonio Gasbarrini, Franco Scaldaferri, Loris Riccardo Lopetuso
  Expert Review of Gastroenterology & Hepatology.2025; 19(8): 833.     CrossRef
• Editorial: Evolving Trends in Ulcerative Colitis Management—Insights From the Lothian Cohort
  Shintaro Akiyama
  Alimentary Pharmacology & Therapeutics.2025; 62(7): 747.     CrossRef
• Examination of the TPMT and NUDT15*3 Variants to Predict the Response to Thiopurines in an Italian Cohort of Patients with Inflammatory Bowel Disease
  Francesca Tavano, Orazio Palmieri, Maria Latiano, Domenica Gioffreda, Tiziana Latiano, Maria Guerra, Giuseppina Martino, Maria Rosa Valvano, Fabrizio Bossa, Francesco Perri, Anna Latiano
  International Journal of Molecular Sciences.2025; 26(16): 7860.     CrossRef
• Assessment of Azathioprine-Associated Lymphopenia Incidence Rates in Polish Children with Inflammatory Bowel Disease and Autoimmune Hepatitis: A Retrospective Study
  Katarzyna Bąk-Drabik, Anna Kaput, Anna Jarzumbek, Katarzyna Górowska-Kowolik, Agnieszka Szymlak, Agnieszka Krzywicka, Piotr Adamczyk, Jarosław Kwiecień
  Children.2025; 12(8): 1093.     CrossRef
• Inflammatory bowel disease in paediatrics: Navigating the old challenges and emerging frontiers
  Mohammed Al-Beltagi, Nermin K Saeed, Prabu Kumar Chokkalingam Mani, Adel S Bediwy, Reem Elbeltagi
  World Journal of Gastroenterology.2025;[Epub]     CrossRef
• Enhancing Crohn’s disease management during pregnancy: innovations in therapeutic approaches and cutting-edge monitoring practices
  Mustafa Goksu, Ozan Karadeniz, Aycan Orler, Pinar Kadirogullari
  BMC Pregnancy and Childbirth.2025;[Epub]     CrossRef
• Inflammatory Bowel Disease and Pharmacotherapeutic Treatment for Healthcare Providers: A Pedagogic Tutorial
  Charlotte Silvestre, Julien Antih, Baptiste Perrier, Lucas Fabrega, Florence Bichon, Patrick Poucheret
  Gastrointestinal Disorders.2025; 7(3): 58.     CrossRef
• Recent developments in biomarker guided therapy for Crohn’s disease
  André Bargas, Joana Torres, Bram Verstockt
  Expert Review of Gastroenterology & Hepatology.2025; 19(12): 1241.     CrossRef
• Comparison of Azathioprine-Induced Pancreatitis and Gastrointestinal Intolerance in IBD: Role of Demographics, Clinical Variables, and HLA DQA1/DRB1 Alleles
  Tugce Eskazan, Oguz Kagan Bakkaloglu, Murat Toruner, Haluk Tarik Kani, Bilger Cavus, Volkan Yilmaz, Nalan Gulsen Unal, Ozlen Atug, Burhan Cagcag, Mehtap Dogruel, Erkan Yilmaz, Filiz Akyuz, Yusuf Ziya Erzin, Ali Ibrahim Hatemi, Aykut Ferhat Celik
  Journal of Clinical Medicine.2025; 14(23): 8539.     CrossRef
• Drug-induced liver injury in inflammatory bowel disease: Challenges in diagnosis and monitoring
  Arshdeep Singh, Arshia Bhardwaj, Harmeet Kaur, Ashutosh Bawa, Vandana Midha, Ajit Sood
  World Journal of Hepatology.2025;[Epub]     CrossRef
• Medical Management of Inflammatory Bowel Disease
  Shahrose Rahman, Ranish K. Patel, Elisa Boden, Vassiliki Liana Tsikitis
  Surgical Clinics of North America.2024; 104(3): 657.     CrossRef
• Tofacitinib Versus Oral Prednisolone for Induction of Remission in Moderately Active Ulcerative Colitis [ORCHID]: A Prospective, Open-Label, Randomized, Pilot Study
  Arshdeep Singh, Vandana Midha, Kirandeep Kaur, Ramit Mahajan, Dharmatma Singh, Ramandeep Kaur, Aditya Kohli, Avantika Chawla, Kriti Sood, Namita Bansal, Ajit Sood
  Journal of Crohn's and Colitis.2024; 18(2): 300.     CrossRef
• Differential molecular mechanisms of substrate recognition by selenium methyltransferases, INMT and TPMT, in selenium detoxification and excretion
  Yasunori Fukumoto, Rin Kyono, Yuka Shibukawa, Yu-ki Tanaka, Noriyuki Suzuki, Yasumitsu Ogra
  Journal of Biological Chemistry.2024; 300(2): 105599.     CrossRef
• Factors Associated with Reaching Mid-Parental Height in Patients Diagnosed with Inflammatory Bowel Disease in Childhood and Adolescent Period
  So Yoon Choi, Sujin Choi, Byung-Ho Choe, Jae Hong Park, Kwang-Hae Choi, Hae Jeong Lee, Ji Sook Park, Ji-Hyun Seo, Jae Young Kim, Hyo-Jeong Jang, Suk Jin Hong, Eun Young Kim, Yeoun Joo Lee, Ben Kang
  Gut and Liver.2024; 18(1): 106.     CrossRef
• Tofacitinib in Acute Severe Ulcerative Colitis (TACOS): A Randomized Controlled Trial
  Arshdeep Singh, Manjeet Kumar Goyal, Vandana Midha, Ramit Mahajan, Kirandeep Kaur, Yogesh Kumar Gupta, Dharmatma Singh, Namita Bansal, Ramandeep Kaur, Shivam Kalra, Omesh Goyal, Varun Mehta, Ajit Sood
  American Journal of Gastroenterology.2024; 119(7): 1365.     CrossRef
• Effectiveness of Tofacitinib in Ulcerative Proctitis Compared to Left Sided Colitis and Pancolitis
  Arshdeep Singh, Ramit Mahajan, Vandana Midha, Kirandeep Kaur, Dharmatma Singh, Ramandeep Kaur, Shreya Garg, Kirti Arora, Namita Bansal, Ajit Sood
  Digestive Diseases and Sciences.2024; 69(4): 1389.     CrossRef
• Uphill battle: Innovation of thiopurine therapy in global inflammatory bowel disease care
  Ahmed B. Bayoumy, Chris J. J. Mulder, Azhar R. Ansari, Murray L. Barclay, Tim Florin, Marianne Kiszka-Kanowitz, Luc Derijks, Vishal Sharma, Nanne K. H. de Boer
  Indian Journal of Gastroenterology.2024; 43(1): 36.     CrossRef
• The drug-survival of low-dose thioguanine in patients with inflammatory bowel disease: a retrospective observational study
  Helena Gensmyr-Singer, Mårten Werner, Pontus Karling
  Therapeutic Advances in Gastroenterology.2024;[Epub]     CrossRef
• Thiopurine Metabolite Shunting in Late Pregnancy Increases the Risk of Intrahepatic Cholestasis of Pregnancy in Women With Inflammatory Bowel Disease, and Can be Managed With Split Dosing
  Ralley Prentice, Emma Flanagan, Emily Wright, Lani Prideaux, William Connell, Miles Sparrow, Peter De Cruz, Mark Lust, Winita Hardikar, Rimma Goldberg, Sara Vogrin, Kirsten Palmer, Alyson Ross, Megan Burns, Tessa Greeve, Sally Bell
  Journal of Crohn's and Colitis.2024; 18(7): 1081.     CrossRef
• Optimal Treatment Approaches to Intestinal Behçet's Disease Complicated by Myelodysplastic Syndrome: The KASID and KSBD Multicenter Study
  Jung-Bin Park, So Jung Han, Seung Bum Lee, Dong Hyun Kim, Jae Hee Cheon, Sung Wook Hwang, Byong Duk Ye, Suk-Kyun Yang, Soo Jung Park, Sang Hyoung Park
  Yonsei Medical Journal.2024; 65(5): 265.     CrossRef
• Application of Drug Repurposing Approach for Therapeutic Intervention of Inflammatory Bowel Disease
  Mohammad Aadil Bhat, Iqra Usman, Suneela Dhaneshwar
  Current Reviews in Clinical and Experimental Pharmacology.2024; 19(3): 234.     CrossRef
• Selecting first-line advanced therapy for ulcerative colitis: A clinical application of personalized medicine
  Mariam S. Mukhtar, Mahmoud H. Mosli
  Saudi Journal of Gastroenterology.2024; 30(3): 126.     CrossRef
• Clinical Significance of Prognostic Nutrition Index in Patients with Crohn’s Disease after Primary Bowel Resection
  Hyeon Woo Bae, Yong Joon Lee, Min Young Park, Seung Yoon Yang, Yoon Dae Han, Min Soo Cho, Hyuk Hur, Kang Young Lee, Jae Hee Cheon, Joseph C. Carmichael, Byung Soh Min
  Yonsei Medical Journal.2024; 65(7): 380.     CrossRef
• Differences in the risk of clinical failure between thiopurine and methotrexate in bio-naïve patients with Crohn’s disease: a Korean nationwide population-based study
  Yu Kyung Jun, Eunjeong Ji, Hye Ran Yang, Yonghoon Choi, Cheol Min Shin, Young Soo Park, Nayoung Kim, Dong Ho Lee, Hyuk Yoon
  Therapeutic Advances in Gastroenterology.2024;[Epub]     CrossRef
• Effectiveness of Switching to Subcutaneous Infliximab in Ulcerative Colitis Patients Experiencing Intravenous Infliximab Failure
  June Hwa Bae, Jung-Bin Park, Ji Eun Baek, Seung Wook Hong, Sang Hyoung Park, Dong-Hoon Yang, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Sung Wook Hwang
  Gut and Liver.2024; 18(4): 667.     CrossRef
• Reply: Predicting Adverse Events to Thiopurines in IBD: Are We a Step Closer?
  Tracy Coelho, Guo Cheng, Fernando Vazquez Lopez, James J Ashton, Robert M Beattie, Sarah Ennis
  Inflammatory Bowel Diseases.2024; 30(10): 1928.     CrossRef
• Safety and Effectiveness of Thiopurines and Small Molecules in Elderly Patients with Inflammatory Bowel Diseases
  Aleksandra Strigáč, Miłosz Caban, Ewa Małecka-Wojciesko, Renata Talar-Wojnarowska
  Journal of Clinical Medicine.2024; 13(16): 4678.     CrossRef
• Harnessing a Safe Novel Lipid Nanoparticle: Targeted Oral Delivery to Colonic Epithelial and Macrophage Cells in a Colitis Mouse Model
  Rabeya Jafrin Mow, Michal Pawel Kuczma, Xiaodi Shi, Sridhar Mani, Didier Merlin, Chunhua Yang
  Nanomaterials.2024; 14(22): 1800.     CrossRef
• Personalization of thiopurine therapy: Current recommendations and future perspectives
  Dunja Urbančič, Flaka Pasha, Alenka Šmid, Irena Mlinarič-Raščan
  Acta Pharmaceutica.2024; 74(3): 355.     CrossRef
• Navigating the pharmacotherapeutic management of comorbid inflammatory bowel disease and primary sclerosing cholangitis
  Brigid Pinnuck, Kate D. Lynch
  Expert Opinion on Pharmacotherapy.2024; 25(13): 1835.     CrossRef
• Ulcerative colitis: molecular insights and intervention therapy
  Yuqing Liang, Yang Li, Chehao Lee, Ziwei Yu, Chongli Chen, Chao Liang
  Molecular Biomedicine.2024;[Epub]     CrossRef
• Drug Interaction-Informed Approaches to Inflammatory Bowel Disease Management
  Kyeong-Ryoon Lee, Aneela Gulnaz, Yoon-Jee Chae
  Pharmaceutics.2024; 16(11): 1431.     CrossRef
• Dramatic Changes in Thiopurine Metabolite Levels in a Patient With Inflammatory Bowel Disease Treated With Tirzepatide for Weight Loss
  Jeremy A. Klein, Joëlle St-Pierre, David Choi, Jacqueline Lopez, David T. Rubin
  ACG Case Reports Journal.2024; 11(11): e01544.     CrossRef
• Thiopurine therapy in inflammatory bowel disease in the pandemic era: Safe or unsafe?
  Shailesh Perdalkar, Pooja Basthi Mohan, Balaji Musunuri, Siddheesh Rajpurohit, Shiran Shetty, Krishnamurthy Bhat, Cannanore Ganesh Pai
  International Immunopharmacology.2023; 116: 109597.     CrossRef
• Effectiveness and safety of thioguanine as a maintenance therapy of inflammatory bowel disease: Systematic review, meta-analysis and meta-regression
  Anuraag Jena, Pardhu B Neelam, Harshavardhan Telaprolu, Uday Kiran Mangipudi, Usha Dutta, Shaji Sebastian, Vishal Sharma
  Clinics and Research in Hepatology and Gastroenterology.2023; 47(7): 102155.     CrossRef
• Impact of Crohn’s Disease on the Survival of Patients with Small-Bowel Adenocarcinoma in Korea: A Bicenter Cohort Study
  Kyuwon Kim, Kookhwan Choi, Sung Wook Hwang, Jong Pil Im, Byong Duk Ye, Joo Sung Kim, Kyu Joo Park, Suk-Kyun Yang, Seong-Joon Koh, Sang Hyoung Park
  Gut and Liver.2023; 17(4): 581.     CrossRef
• Infectious complications in patients with inflammatory bowel disease in Asia: the results of a multinational web-based survey in the 8th Asian Organization for Crohn’s and Colitis meeting
  Yu Kyung Jun, Seong-Joon Koh, Dae Seong Myung, Sang Hyoung Park, Choon Jin Ooi, Ajit Sood, Jong Pil Im
  Intestinal Research.2023; 21(3): 353.     CrossRef
• The Management of Inflammatory Bowel Disease during Reproductive Years: An Updated Narrative Review
  Nariman Hossein-Javaheri, Michael Youssef, Yaanu Jeyakumar, Vivian Huang, Parul Tandon
  Reproductive Medicine.2023; 4(3): 180.     CrossRef
• Long‐term safety and effectiveness of azathioprine in the management of inflammatory bowel disease: A real‐world experience
  Rohan V Yewale, Balakrishnan S Ramakrishna, Babu Vinish Doraisamy, Pandurangan Basumani, Jayanthi Venkataraman, Kayalvizhi Jayaraman, Ananthavadivelu Murali, Karunakaran Premkumar, Akkim Sathish Kumar
  JGH Open.2023; 7(9): 599.     CrossRef
• Effectiveness and tolerability of methotrexate monotherapy in Crohn’s disease patients: a multicenter observational study
  Jihye Park, Jaeyoung Chun, Soo Jung Park, Jae Jun Park, Tae Il Kim, Hyuk Yoon, Jae Hee Cheon
  Therapeutic Advances in Gastroenterology.2023;[Epub]     CrossRef
• Oral Lingzhi or Reishi Medicinal Mushroom Ganoderma lucidum (Agaricomycetes) Spore Powder Ameliorates Murine Colitis by Inhibiting Key Kinases Phosphorylation in MAPK Pathway
  Yingying Zhao, Liangchen Zhu
  International Journal of Medicinal Mushrooms.2023; 25(10): 39.     CrossRef
• Enhancing cancer therapy: The potential of mercaptopurine-based nanomaterials for targeted drug delivery
  Mehrab Pourmadadi, Arsalan Rahmani Ghohrodi, Zeinab Savari, Ehsan Talebi, Iman Ahamdi, Abbas Rahdar, Sadanand Pandey
  Next Nanotechnology.2023; 2: 100018.     CrossRef
• Thiopurine Exposure During Pregnancy is Not Associated With Anemia in Infants Born to Mothers With IBD
  Fiona Yeaman, Amelie Stritzke, Verena Kuret, Nastaran Sharifi, Cynthia H Seow, Amy Metcalfe, Yvette Leung
  Crohn's & Colitis 360.2023;[Epub]     CrossRef
• Reviewing the potential of probiotics, prebiotics and synbiotics: advancements in treatment of ulcerative colitis
  Apurva Jadhav, Suresh Jagtap, Suresh Vyavahare, Archana Sharbidre, Bipinraj Kunchiraman
  Frontiers in Cellular and Infection Microbiology.2023;[Epub]     CrossRef
• Impact of Immunosuppressive Therapy on the Performance of Latent Tuberculosis Screening Tests in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
  Chan Hyuk Park, Jung Ho Park, Yoon Suk Jung
  Journal of Personalized Medicine.2022; 12(3): 507.     CrossRef
• Use of Azathioprine in Ulcerative Colitis: A Comprehensive Review
  Bipadabhanjan Mallick, Sarthak Malik
  Cureus.2022;[Epub]     CrossRef
• Ulcerative Colitis in Adulthood and in Older Patients: Same Disease, Same Outcome, Same Risks?
  Walter Fries, Maria Giulia Demarzo, Giuseppe Navarra, Anna Viola
  Drugs & Aging.2022; 39(6): 441.     CrossRef
• Personalized medicine in inflammatory bowel disease: Perspectives on Asia
  Su Hyun Park, Sang Hyoung Park
  Journal of Gastroenterology and Hepatology.2022; 37(8): 1434.     CrossRef
• Prevention of postoperative recurrence in Crohn’s disease: the never-ending story
  Jung-Bin Park, Sang Hyoung Park
  Intestinal Research.2022; 20(3): 279.     CrossRef
• Updates on conventional therapies for inflammatory bowel diseases: 5-aminosalicylates, corticosteroids, immunomodulators, and anti-TNF-α
  Jihye Park, Jae Hee Cheon
  The Korean Journal of Internal Medicine.2022; 37(5): 895.     CrossRef
• Viral Hepatitis in Patients with Inflammatory Bowel Disease
  Seung Hwan Shin, Sang Hyoung Park
  The Korean Journal of Gastroenterology.2022; 80(2): 51.     CrossRef
• Vaccination strategies for Korean patients with inflammatory bowel disease
  Yoo Jin Lee, Eun Soo Kim
  The Korean Journal of Internal Medicine.2022; 37(5): 920.     CrossRef
• Effectiveness and Safety of Golimumab in Patients with Ulcerative Colitis: A Multicenter, Prospective, Postmarketing Surveillance Study
  Jongwook Yu, Soo Jung Park, Hyung Wook Kim, Yun Jeong Lim, Jihye Park, Jae Myung Cha, Byong Duk Ye, Tae Oh Kim, Hyun-Soo Kim, Hyun Seok Lee, Su Young Jung, Youngdoe Kim, Chang Hwan Choi
  Gut and Liver.2022; 16(5): 764.     CrossRef
• A report on the potential of Rac1/pSTAT3 protein levels in T lymphocytes to assess the pharmacodynamic effect of thiopurine therapy in Inflammatory Bowel Disease patients
  Debbie S. Deben, Rob H. Creemers, Arjan J. van Adrichem, Roosmarie Drent, Audrey H. H. Merry, Mathie P. G. Leers, Adriaan A. van Bodegraven, Dennis R. Wong
  Scientific Reports.2022;[Epub]     CrossRef
• Low-Dose Azathioprine in Combination with Allopurinol: The Past, Present and Future of This Useful Duo
  Alexander Keith Turbayne, Miles Patrick Sparrow
  Digestive Diseases and Sciences.2022; 67(12): 5382.     CrossRef
• NUDT15Genotyping in Thiopurine Drug Therapy
  Jong Kwon Lee, Rihwa Choi, Soo-Youn Lee
  Laboratory Medicine Online.2022; 12(4): 217.     CrossRef
• Personalized medicine to implementation science: Thiopurines set for the leap
  Vishal Sharma, Saurabh Kedia, Vineet Ahuja
  JGH Open.2022; 6(10): 651.     CrossRef
• Immunomodulators: still having a role?
  Jeffery M Venner, Charles N Bernstein
  Gastroenterology Report.2022;[Epub]     CrossRef
• Treatment of inflammatory bowel diseases: focusing on 5-aminosalicylates and immunomodulators
  You Sun Kim
  Journal of the Korean Medical Association.2021; 64(9): 596.     CrossRef
• Is the Long-term Disease Course of Elderly-Onset Ulcerative Colitis Different from That of Non-Elderly-Onset Ulcerative Colitis?
  Jin Wook Lee, Eun Soo Kim
  Gut and Liver.2021; 15(5): 639.     CrossRef
• Pharmacogenetics-based personalized treatment in patients with inflammatory bowel disease: A review
  Ji Young Chang, Jae Hee Cheon
  Precision and Future Medicine.2021; 5(4): 151.     CrossRef
• Current status and future perspectives on the use of therapeutic drug monitoring of thiopurine metabolites in patients with inflammatory bowel disease
  Debbie S. Deben, Dennis R. Wong, Adriaan A. van Bodegraven
  Expert Opinion on Drug Metabolism & Toxicology.2021; 17(12): 1433.     CrossRef

Citations

Citations to this article as recorded by  

• The Overlap Between Crohn’s Disease and Intestinal Tuberculosis: A Never-Ending Story
  Sergiu Marian Cazacu, Costin Teodor Streba, Cristian Constantin, Claudiu Marinel Ionele, Ion Rogoveanu, Alexandru Valentin Popescu, Mirela-Marinela Florescu
  Medicina.2026; 62(4): 794.     CrossRef
• Current Progress in Differentiating Crohn's Disease From Intestinal Tuberculosis
  Chuyao Zhang, Xiaoyin Zhang
  iLABMED.2026; 4(2): 78.     CrossRef
• FoxP3-positive T regulatory cells and its effector mechanisms in Crohn’s disease: an immunohistochemical and image morphometric analysis on endoscopic mucosal biopsies
  Susama Patra, Shalini Chaudhary, Subash Chandra Samal, Pavithra Ayyanar, Somanath Padhi, Hemanta Kumar Nayak, Amit Kumar Satapathy, Saurav Nayak, Ajit Sahu, Tapaskanti Parida, Mohammed Shahin
  European Journal of Gastroenterology & Hepatology.2025; 37(7): 799.     CrossRef
• New diagnostic strategies to distinguish Crohn's disease and gastrointestinal tuberculosis
  Himanshu Narang, Saurabh Kedia, Vineet Ahuja
  Current Opinion in Infectious Diseases.2024; 37(5): 392.     CrossRef
• Evidence-based approach to diagnosis and management of abdominal tuberculosis
  Daya Krishna Jha, Mythili Menon Pathiyil, Vishal Sharma
  Indian Journal of Gastroenterology.2023; 42(1): 17.     CrossRef
• Gut Microbiome in Probable Intestinal Tuberculosis and Changes following Anti-Tuberculosis Treatment
  Hyuk Yoon, Young Soo Park, Cheol Min Shin, Nayoung Kim, Dong Ho Lee
  Yonsei Medical Journal.2022; 63(1): 34.     CrossRef
• Single-nucleotide polymorphisms and activities of indoleamine 2,3-dioxygenase isoforms, IDO1 and IDO2, in tuberculosis patients
  Tingming Cao, Guangming Dai, Hongqian Chu, Chengcheng Kong, Huijuan Duan, Na Tian, Zhaogang Sun
  Hereditas.2022;[Epub]     CrossRef
• Recent advances in the diagnosis of intestinal tuberculosis
  Hasan Maulahela, Marcellus Simadibrata, Erni Juwita Nelwan, Nur Rahadiani, Editha Renesteen, S. W. T. Suwarti, Yunita Windi Anggraini
  BMC Gastroenterology.2022;[Epub]     CrossRef
• Addition of computed tomography chest increases the diagnosis rate in patients with suspected intestinal tuberculosis
  Saurabh Kedia, Raju Sharma, Sudheer Kumar Vuyyuru, Deepak Madhu, Pabitra Sahu, Bhaskar Kante, Prasenjit Das, Ankur Goyal, Karan Madan, Govind Makharia, Vineet Ahuja
  Intestinal Research.2022; 20(2): 184.     CrossRef
• Inflammatory bowel disease in Korea: epidemiology and pathophysiology
  Jung Won Lee, Chang Soo Eun
  The Korean Journal of Internal Medicine.2022; 37(5): 885.     CrossRef
• Intestinal tuberculosis or Crohn's disease: Illusion or delusion or allusion
  Saurabh Kedia, Vineet Ahuja
  JGH Open.2021; 5(2): 177.     CrossRef
• Deep‐learning system for real‐time differentiation between Crohn's disease, intestinal Behçet's disease, and intestinal tuberculosis
  Jung Min Kim, Jun Gu Kang, Sungwon Kim, Jae Hee Cheon
  Journal of Gastroenterology and Hepatology.2021; 36(8): 2141.     CrossRef
• Mycobacterium tuberculosis (MTB) antigen-induced upregulation of interleukin-35 expression in patients with MTB infection: In vitro blockade of the effects of interleukin-35 on T lymphocyte subsets
  Hongbin Jiang, Beinian Cui, Jun Zhang
  Pathogens and Disease.2021;[Epub]     CrossRef

Recent studies have identified sprue-like illness associated with the use of the antihypertensive agent olmesartan medoxomil. However, whether this condition is specific to the use of olmesartan or is associated with the use of drugs belonging to the class of “sartans” remains to be clarified. A 45-year-old woman with chronic kidney disease along with hypothyroidism and hypertension presented with chronic diarrhea and significant weight loss. Endoscopy of the upper gastrointestinal tract showed scalloping and grooving of the duodenum, and histopathological examination showed subtotal villous atrophy. She was on telmisartan for hypertension, which was discontinued. Subsequently, diarrhea ameliorated dramatically, and she regained weight. To our knowledge, this is the first study to report telmisartan-associated sprue-like enteropathy. Further, we have reviewed the cases of patients with sprue-like enteropathy caused by valsartan, irbesartan, and eprosartan.

Citations

Citations to this article as recorded by  

• Case Report: Olmesartan-Induced Enteropathy Mimicking Amyloidosis in the Setting of New Multiple Myeloma Diagnosis
  Mohamad Mahdi Osman, Moises Salgado-de la Mora, Rishaan Sharma, Abdelwahab Ahmed, Sima Fansa, Talal Massad, Hussam Kawas, Mohamed El Hag, Vitaliy Rotenberg
  Case Reports in Gastroenterology.2026; 20(1): 210.     CrossRef
• Olmesartan induced gastritis and enteropathy
  Ankur Gupta, Priyanka Jain, Latika Gupta
  Indian Journal of Gastroenterology.2024; 43(3): 684.     CrossRef
• Systematic review: Clinical phenotypes, histopathological features and prognosis of enteropathy due to angiotensin II receptor blockers
  Annalisa Schiepatti, Paolo Minerba, Michele Puricelli, Stiliano Maimaris, Giovanni Arpa, Federico Biagi, David S. Sanders
  Alimentary Pharmacology & Therapeutics.2024; 59(4): 432.     CrossRef
• Olmesartan induced enteropathy affecting the entire gastrointestinal tract: a case report
  N Van Horebeek, R Croes, A Vonck, E Colpaert
  Acta Gastro Enterologica Belgica.2023; 86(1): 95.     CrossRef
• A Case of Sprue-like Enteropathy Associated With Valsartan and Irbesartan
  Seo Yeon Yoo, Jihun Kim, Kee Wook Jung
  Journal of Neurogastroenterology and Motility.2022; 28(2): 327.     CrossRef
• The histological spectrum of ARB‐induced gastritis
  Tanner Storozuk, Ian Brown, Stephen Lagana, Maria Westerhoff, Namrata Setia, John Hart, Lindsay Alpert
  Histopathology.2022; 81(5): 653.     CrossRef
• Severe cases of sprue‐like enteropathy associated with angiotensin receptor blockers other than olmesartan
  Peter Malfertheiner, Chiara Formigoni
  GastroHep.2021; 3(2): 88.     CrossRef
• Telmisartan-induced sprue-like enteropathy: a case report
  Natalia Alzueta, Amaya Echeverría, Lorea Sanz, Carmen Fontela, Teresa Acín, Lidia Montenegro, Javier Garjón
  European Journal of Hospital Pharmacy.2020; 27(1): 49.     CrossRef
• Olmesartan Associated Enteropathy: Usefulness of Video Capsule Endoscopy in a Case With Doubtful Upper Endoscopic/Histological Picture
  Francesco Abbruzzi, Ilaria Loconte, Sonia Carparelli, Enzo Ierardi, Alfredo Di Leo, Mariabeatrice Principi
  Current Drug Safety.2020; 15(1): 65.     CrossRef
• Traitement par olmésartan et entéropathie : à propos de deux cas et revue de la littérature
  A. Sadki, M. Le Besnerais, F. Héron, I. Marie
  La Revue de Médecine Interne.2019; 40(2): 112.     CrossRef
• A simple treatment for a potentially life-threatening cause of malabsorption
  Mattia Bonzi, Elisa M. Fiorelli, Gaia Montanelli, Ludovico Furlan, Monica Solbiati
  Internal and Emergency Medicine.2019; 14(6): 967.     CrossRef
• Angiotensin II receptor blockers and gastrointestinal adverse events of resembling sprue-like enteropathy: a systematic review
  Ayesha Kamal, Christopher Fain, Angela Park, Peiqi Wang, Eduardo Gonzalez-Velez, Daniel A Leffler, Susan M Hutfless
  Gastroenterology Report.2019; 7(3): 162.     CrossRef
• Association of sprue-like enteropathy and angiotensin receptor-1 antagonists
  René R. Wenzel, Christian Datz
  Wiener klinische Wochenschrift.2019; 131(19-20): 493.     CrossRef
• Severe intestinal malabsorption associated with ACE inhibitor or angiotensin receptor blocker treatment. An observational cohort study in Germany and Italy
  Peter Malfertheiner, Claudio Ripellino, Nazarena Cataldo
  Pharmacoepidemiology and Drug Safety.2018; 27(6): 581.     CrossRef